Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹18 Cr
Revenue (TTM)
₹0 Cr
Net Profit (TTM)
₹0 Cr
ROE
9.8 %
ROCE
13.5 %
P/E Ratio
51.4
P/B Ratio
1.3
Industry P/E
13.21
EV/EBITDA
13.9
Div. Yield
0 %
Debt to Equity
0
Book Value
₹87.6
EPS
₹2.3
Face value
10
Shares outstanding
1,500,000
CFO
₹1.26 Cr
EBITDA
₹-5.24 Cr
Net Profit
₹6.30 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Chemo-Pharma Lab
| 7.0 | -13.1 | 4.1 | 91.4 | 51.5 | 76.7 | -- |
|
BSE 500
| 2.6 | 1.5 | 7.8 | 2.8 | 20.2 | 21.8 | 12.7 |
|
BSE Small Cap
| -3.9 | 2.7 | 11.4 | 1.4 | 30.2 | 33.5 | 16.9 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Chemo-Pharma Lab
| 63.2 | 59.0 | 25.0 | 17.9 | 279.5 | -74.9 | -31.3 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE 500
| 14.4 | 24.8 | 3.3 | 30.1 | 16.8 | 7.8 | -3.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Chemo-Pharma Lab
|
117.6 | 17.6 | 0.0 | 0.4 | -- | 2.6 | 51.4 | 1.3 |
| 205.5 | 3,513.3 | 2,515.6 | 194.8 | 10.0 | 14.2 | 13.2 | 1.8 | |
| 29.9 | 118.0 | 268.4 | 9.8 | 5.6 | 12.5 | 12 | 1.6 | |
| 49.2 | 60.6 | 86.5 | 3.4 | -- | 22.4 | 13.5 | 3.2 | |
| 326.0 | 3,055.2 | 86.7 | -16.2 | -17.6 | -14 | -- | 18.8 | |
| 70.0 | 10,506.0 | 2.7 | 69.5 | -5,322.3 | 5.1 | 121.3 | 6.2 | |
| 584.8 | 16,549.9 | 3,983.6 | 1,434.0 | 37.2 | 14.6 | 15.2 | 2.2 | |
| 604.0 | 546.6 | 71.0 | 9.9 | -- | 11.8 | 34.4 | 5.3 | |
| 23.1 | 9.2 | 0.0 | -0.4 | -- | -10.1 | -- | 2.5 | |
| 888.0 | 226.4 | 105.1 | 27.2 | 10.0 | 11.4 | 11 | 2.7 |
No Review & Analysis are available.
Chemo Pharma Laboratories Limited does not have significant operations. Previously, it was engaged in the finance and investment activities. The company was founded in 1942 and is based in Mumbai, India.
Incorporated
1942
Chairman
--
Managing Director
--
Headquarters
Thane, Maharashtra
Website
Looking for more details about Chemo-Pharma Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Chemo-Pharma Laboratories Ltd stood at ₹ 13 Cr as on 31-Mar-25
The share price of Chemo-Pharma Laboratories Ltd is ₹117.55 (BSE) as of 23-Jun-2025 IST. Chemo-Pharma Laboratories Ltd has given a return of 51.51% in the last 3 years.
Chemo-Pharma Laboratories Ltd has a market capitalisation of ₹ 18 Cr as on 23-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Chemo-Pharma Laboratories Ltd is 1.34 times as on 23-Jun-2025, a 38% discount to its peers’ median range of 2.17 times.
The P/E ratio of Chemo-Pharma Laboratories Ltd is 51.41 times as on 23-Jun-2025, a 289% premium to its peers’ median range of 13.21 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Chemo-Pharma Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Chemo-Pharma Laboratories Ltd.
Chemo Pharma Laboratories Limited does not have significant operations. Previously, it was engaged in the finance and investment activities. The company was founded in 1942 and is based in Mumbai, India.
The promoters of Chemo-Pharma Laboratories Ltd are CITRIC INDIA LTD and SHANTA SOMANI. They collectively own 27.88 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Chemo-Pharma Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
3,476
|
|
|
2,910
|
|
|
553
|
|
|
221
|
|
|
126
|
|
|
61
|
|
|
9
|
|
|
16,073
|
|
|
10,052
|
| Chemo-Pharma Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
2.59
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
55.97
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Chemo-Pharma Laboratories Ltd was ₹0 Cr.
